Patents Assigned to The Foundation For Innovative Therapies, Inc.
  • Patent number: 7012086
    Abstract: Chronic infection with retroviruses, such as HIV, induce a number of metabolic derangements. The present invention relates to a method for treating retrovirus-infected subjects with niacin compounds to reverse infection induced metabolic derangements.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: March 14, 2006
    Assignee: The Foundation For Innovative Therapies, Inc.
    Inventor: Michael F. Murray